DR. DIAA OSMAN DO NPI 1689894495

NPI Information

  • NPI: 1689894495
  • Provider Name: DR. DIAA OSMAN, DO
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4101 JAMES CASEY ST STE 100
    AUSTIN, TX
    ZIP 78745
  • Phone: (512) 447-2202

Map and Directions

Get Directions

NPI Details

DR. Diaa Osman, DO is a hematology and oncology internal medicine in Austin, TX with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Diaa Osman, DO NPI is 1689894495. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4101 JAMES CASEY ST STE 100
AUSTIN, TX
ZIP 78745-145
Phone: (512) 447-2202
Fax: (512) 447-5337

The NPI 1689894495 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Ct scan of chest with contrast (HCPCS:71260)

The enumeration date for this NPI number is 4/26/2007 and was last updated on 8/30/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology63605MINNESOTANo
2207RH0003XInternal MedicineHematology & OncologyQ3567TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.